Intellinetics Secures Largest Contract in Company History

Intellinetics ( (INLX) ) just unveiled an update.

On May 28, 2025, Graphic Sciences, Inc., a subsidiary of Intellinetics, Inc., secured a five-year contract renewal with the State of Michigan for document management services, valued at an estimated $42.75 million. This contract, effective from June 1, 2025, to May 30, 2030, allows Michigan’s subdivisions and agencies to procure services at a fixed price, though the contract can be terminated under certain conditions. Separately, Intellinetics announced its largest contract in company history, a $40 million agreement for document scanning and conversion services, set to begin on June 1, 2025. This contract was awarded after a competitive evaluation process and positions Intellinetics to focus on delivering high-quality services and exploring further revenue opportunities, particularly in SaaS solutions.

Spark’s Take on INLX Stock

According to Spark, TipRanks’ AI Analyst, INLX is a Neutral.

The overall stock score of 56 reflects Intellinetics’ stable financial position and effective cash flow management, which are overshadowed by operational challenges and negative valuation metrics due to net losses. Technical indicators provide a neutral outlook, further impacting the score.

To see Spark’s full report on INLX stock, click here.

More about Intellinetics

Intellinetics, Inc. is a digital transformation solutions provider based in Columbus, Ohio. The company offers a range of services including the IntelliCloud™ content management platform, business process outsourcing, document and micrographics scanning services, and records storage. It serves highly regulated markets such as healthcare, human services, K-12 education, public safety, and state and local governments, focusing on enabling organizations to manage, store, and protect important documents and data.

Average Trading Volume: 5,478

Technical Sentiment Signal: Buy

Current Market Cap: $54.97M

Learn more about INLX stock on TipRanks’ Stock Analysis page.